Related Experiment Video
Updated: Dec 14, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
PCYT1A suppresses proliferation and migration via inhibiting mTORC1 pathway in lung adenocarcinoma
Jing Yu1, Changtao Wu2, Qi Wu3
1Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
Abstract:
Lung cancer is one of most common malignant cancer worldwide. It is emerging that PCYT1A, a rate-limiting enzyme required for the biosynthesis of phosphatidylcholine, is associated with cancer progression. However, the biological functions and underlying molecular mechanisms of PCYT1A in lung adenocarcinoma is still unknown. Here we found that PCYT1A suppressed lung adenocarcinoma cancer cell proliferation and migration. Mechanically, PCYT1A served as a novel negative regulator of mTORC1 signaling. PCYT1A knockdown enhanced the malignant proliferation and migration of lung adenocarcinoma cells by activating mTORC1. The promoting effects of PCYT1A silencing on cell proliferation and migration could be abolished when mTORC1 signaling was inhibited by rapamycin or RAPTOR depletion. Importantly, PCYT1A high expression predicted longer survival of lung cancer patients. The expression of PCYT1A was also negatively correlated with mTORC1 activation in the clinical lung cancer samples. We therefore reveal that PCYT1A suppresses proliferation and migration by inhibiting the mTORC1 signaling pathway in lung adenocarcinoma. PCYT1A shows as a potential promising biomarker in lung adenocarcinoma.
Insights
Phosphatidylcholine biosynthesis enzyme PCYT1A suppresses lung adenocarcinoma cell growth and migration by inhibiting mTORC1 signaling. High PCYT1A expression correlates with better lung cancer patient survival, indicating its potential as a biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Lung adenocarcinoma is a prevalent malignancy with complex progression mechanisms.
- The role of PCYT1A (cytidine triphosphate:phosphocholine cytidylyltransferase) in lung adenocarcinoma remains largely uncharacterized.
- PCYT1A is a key enzyme in phosphatidylcholine biosynthesis, essential for cell membrane integrity and signaling.
Purpose of the Study:
- To elucidate the biological functions and molecular mechanisms of PCYT1A in lung adenocarcinoma.
- To investigate the relationship between PCYT1A expression and cancer cell behavior.
- To determine the potential of PCYT1A as a prognostic biomarker in lung cancer.
Main Methods:
- Cell proliferation and migration assays were performed.
- Western blotting was used to assess protein levels and signaling pathway activation.
- The effect of PCYT1A modulation on mTORC1 signaling was examined.
- Correlation analysis was conducted between PCYT1A expression and clinical outcomes in lung cancer patients.
Main Results:
- PCYT1A suppressed lung adenocarcinoma cell proliferation and migration.
- PCYT1A acted as a negative regulator of mTORC1 signaling.
- PCYT1A knockdown enhanced cell proliferation and migration via mTORC1 activation.
- Inhibition of mTORC1 signaling abolished the promoting effects of PCYT1A silencing.
- High PCYT1A expression was associated with longer survival in lung cancer patients.
- PCYT1A expression inversely correlated with mTORC1 activation in clinical samples.
Conclusions:
- PCYT1A inhibits lung adenocarcinoma cell proliferation and migration by suppressing the mTORC1 signaling pathway.
- PCYT1A functions as a tumor suppressor in lung adenocarcinoma.
- PCYT1A is a potential prognostic biomarker for lung adenocarcinoma, with high expression indicating a favorable outcome.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

